CC0 PUBLIC RECORD GRAPH Every score & timeline item links directly to its underlying U.S. FDA record (openFDA, ORA FOIA Reading Room, DECRS & OASIS).
Scoring Formula v2.0 & Legal Guardrails REST API v1
FG
GMPGraphv2.0
Global FDA Facility Graph & Co-Packer Intelligence
Recalls → D-0049-2027
Class III Recall · D-0049-2027 Report Date: 2026-10-28 · Status: Ongoing

Viatris, Inc. — Pharmaceuticals & Sterile/OTC Drugs Recall

Product Description: Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA, Made in India, NDC 0378-1075-93.
Reason for Recall: Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
Distribution Pattern: Nationwide in the USA.
View Linked Facility Profile (FEI FEI-6F145D5E) → Verify on openFDA ↗